- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.06. | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 146 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 24 June 2026. Below follows a summary of the resolutions that were passed at the general meeting
Income... ► Artikel lesen | |
| 13.05. | Simris Group AB: Simris Group Interim Report January-march 2026 | 203 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2026Net revenue increased by 167% to SEK 424k (159k).EBITDA improved by 41% to SEK -2 183k (-3 724k).EBIT/Operating result improved by 23% to SEK -5 626k (-7 288k).KEY EVENTS... ► Artikel lesen | |
| 12.05. | Simris Group AB: Simris Group Advances Asset Divestment Process with Two Prospective Buyers | 340 | GlobeNewswire (Europe) | Simris Group AB (Simris or the Company) today announces progress in its strategic divestment process for its microalgae production facility in Hammenhög, Sweden. Simris has entered into a Memorandum... ► Artikel lesen | |
| 11.03. | Simris Group AB: Simis provides an update on the divestment of its assets in Hammenhög, Sweden | 186 | GlobeNewswire (Europe) | Simris Group AB ("Simris" or the "Company") announces that discussions with Immunrise Biocontrol France SAS ("Immunrise") continue, on a non-exclusive basis, beyond the deadline of March 1, 2026 and... ► Artikel lesen | |
| 28.02. | Simris Group AB: Simris Group Year-end Report January-december 2025 | 476 | GlobeNewswire (Europe) | QUARTER 4, JULY - DECEMBER 2025Net revenue decreased by 71% to SEK 285k (971k).EBITDA declined by 63% to SEK -5 196k (-3 180k).EBIT/Operating result improved by 9% to SEK -8 429 (-9 241k).YEAR-END PERIOD... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 19.01. | Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting | 322 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting.
Election... ► Artikel lesen | |
| 12.11.25 | Simris Group AB receives observation status | 250 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11.25 | Simris Group AB: Simris Group Interim Report January-september 2025 | 276 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11.25 | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 312 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11.25 | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 267 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10.25 | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 341 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09.25 | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 1.008 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08.25 | Simris Group AB: Simris Group Interim Report January-june 2025 | 314 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07.25 | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 303 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,657 | -0,51 % | Neue Meme-Aktie: Wendy's: Angebliche Millionen-Wette eines Reddit-Zockers sorgt für Furore! | © Foto: DALLE (KI-Bild) - OpenAIWendy's wird auf Reddit plötzlich zur Meme-Aktie. Zwischen "Diamond Hands", Kaufparolen, Pleitewarnungen und angeblichen Mega-Wetten zeigt sich: Die Zocker sind bei der... ► Artikel lesen | |
| OATLY GROUP | 8,240 | -2,14 % | The companies most exposed to consumer UPF concerns: Report identifies Oatly, The Hershey Co. and Flowers Foods as most vulnerable | ||
| CONAGRA BRANDS | 12,390 | -1,39 % | Conagra Brands' Quarterly Earnings Preview: What You Need to Know | ||
| WINGSTOP | 154,25 | +0,33 % | Wingstop: Ist der Startschuss zu einer Rallye gerade gefallen? | Ist aus einer kleinen Chicken-Wing-Kette einer der profitabelsten Wachstumswerte der Restaurantbranche geworden Den vollständigen Artikel lesen ... ► Artikel lesen | |
| WH GROUP | 0,965 | +3,85 % | Dividendenbekanntmachungen (13.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSOLENT AIR CARE GROUP AB SE0006256558 3,25 SEK 0,2978 EUR AERCAP HOLDINGS NV NL0000687663 0,4 USD 0,3407 EUR AMBEA AB SE0009663826 2... ► Artikel lesen | |
| MHP | 7,650 | 0,00 % | MHP SE: MHP discussed Global Trade challenges with WTO Director-General in Geneva | KYIV, Ukraine, May 22, 2026 /PRNewswire/ -- On May 12, Mykhailo Bno-Airiian, Vice-President for Global Affairs at MHP, met with Okonjo-Iweala, Director-General of the World Trade Organization... ► Artikel lesen | |
| JACK IN THE BOX | 15,100 | -1,95 % | Short Squeeze bei Jack in the Box: Aktie setzt Rallye mit 10 % Plus fort | ||
| ELSE NUTRITION | 0,005 | 0,00 % | Else Nutrition Holdings Inc (2): Else Nutritional receives conditional CSE listing OK | ||
| J&J SNACK FOODS | 65,50 | 0,00 % | Dividendenbekanntmachungen (16.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADTRAN NETWORKS SE DE0005103006 - 0,52 EUR ALTAGAS LTD CA0213611001 0,334 CAD 0,2059 EUR ALTAGAS LTD PRF.G CA0213618865 0,376 CAD 0... ► Artikel lesen | |
| BIOGAIA | 10,740 | -0,56 % | BioGaia AB's subsidiary introduces a complete skincare routine for babies and children | BioGaia AB's subsidiary, Biogaia New Sciences AB, is expanding its BioGaia® Skincare portfolio with two new products and an updated design across the full range. The expanded skincare line reinforces... ► Artikel lesen | |
| SADOT GROUP | 70,98 | -1,42 % | Sadot Group Inc. - 8-K, Current Report | ||
| CAVA GROUP | 79,79 | 0,00 % | Why the Market Dipped But Cava Group (CAVA) Gained Today | ||
| FIRST WATCH RESTAURANT GROUP | 13,340 | 0,00 % | Why First Watch Restaurant Group Topped the Market Today | ||
| KURA SUSHI USA | 58,02 | 0,00 % | DA Davidson cuts Kura Sushi stock price target on valuation reset | ||
| MAMAS CREATIONS | 18,335 | +0,03 % | Mama's Creations, Inc. - 8-K, Current Report |
SIMRIS GROUP AB gehört der Branche Nahrungsmittel/Agrar an. Der aktuelle Kurs liegt bei 0,003 Euro und damit +14,29 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMRIS GROUP AB finden Sie auf Wallstreet Online.